Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Data-driven comorbidity analysis of 100 common disorders reveals patient subgroups with differing mortality risks and laboratory correlates
Using a lower dose seems to be associated with a reduced risk of hair changes
[P4567]: a phase 1 safety trial of the A oligomer receptor antagonist CT1812
Nasseri, MD , and his team to receive personalized care and experience the benefits of this essential nutrient, helping you feel revitalized and energized
Instead of searching blindly, researchers can now use such models to build and tweak peptides in silico, zeroing in on sequences that might actually work
US$ 25.29
US$ 26.82
US$ 22.10
US$ 22.48
